Bottom line: MeAgain feels more like relief because it brings tracking, context, and Capy into one GLP-1-first experience not another broad program to manage
Pfizer PFE Fair Value Estimate: $42.00 Morningstar Rating: 5 stars Morningstar Economic Moat Rating: Wide Morningstar Uncertainty Rating: Medium We are holding steady to our fair value estimate and wide moat rating for Pfizer following first-quarter results that largely matched our expectations
Some people find the idea intimidating at first, but many products come in prefilled pen devices designed to make dosing simpler
Muscle mass is critical for keeping your metabolism healthy and stable, and losing it can lead to plateaus, rebound weight gain, or poor long-term results
Finally, for GLP-1 receptor agonists, switching between drugs within the same drug class was common, with approximately 1 in 4 patients who initiated treatment with a GLP-1 receptor agonist in our study having switched drug at least once